136 related articles for article (PubMed ID: 19018034)
1. Persistent Candida parapsilosis funguria associated with an indwelling urinary tract stent for more than 7 years.
Ruan SY; Chien JY; Hsueh PR
J Med Microbiol; 2008 Dec; 57(Pt 12):1585-1587. PubMed ID: 19018034
[TBL] [Abstract][Full Text] [Related]
2. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
3. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients.
Schwab U; Chernomas F; Larcom L; Weems J
Diagn Microbiol Infect Dis; 1997 Sep; 29(1):11-7. PubMed ID: 9350410
[TBL] [Abstract][Full Text] [Related]
4. Current management of funguria.
Gubbins PO; McConnell SA; Penzak SR
Am J Health Syst Pharm; 1999 Oct; 56(19):1929-35; quiz 1936. PubMed ID: 10554910
[TBL] [Abstract][Full Text] [Related]
5. Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
QJM; 2016 May; 109(5):325-9. PubMed ID: 26537955
[TBL] [Abstract][Full Text] [Related]
6. Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
Lima GME; Nunes MO; Chang MR; Tsujisaki RAS; Nunes JO; Taira CL; Thomaz DY; Negro GMBD; Mendes RP; Paniago AMM
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e75. PubMed ID: 29267583
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Systemic Fluconazole in Adult Patients With Asymptomatic Candiduria: A Systematic Review and Meta-Analysis.
Chaari A; Ismail M; Abdel Hakim K; Said Mahmoud T; Boussalmi K; Elsaka A; Al Khaja M; Kauts V; Casey WF
Am J Ther; 2017; 24(6):e758-e762. PubMed ID: 26938755
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
[TBL] [Abstract][Full Text] [Related]
9. [Management of fungal urinary tract infections].
Etienne M; Caron F
Presse Med; 2007 Dec; 36(12 Pt 3):1899-906. PubMed ID: 17544611
[TBL] [Abstract][Full Text] [Related]
10. Biofilm formation by Candida species on intrauretheral catheter and its antifungal susceptibility profile.
Chaudhary S; Gupta C; Das S; Saha R; Rani M; Ramachandran VG
Indian J Med Microbiol; 2014; 32(4):467-8. PubMed ID: 25297047
[No Abstract] [Full Text] [Related]
11. Antifungal susceptibilities of Candida species isolated from urine culture.
Toka Özer T; Durmaz S; Yula E
J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
[TBL] [Abstract][Full Text] [Related]
12. Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp.
Chiew YF; Inwood H
N Z Med J; 2007 Jun; 120(1255):U2567. PubMed ID: 17546112
[No Abstract] [Full Text] [Related]
13. Catheter-associated candiduria: Risk factors, medical interventions, and antifungal susceptibility.
Padawer D; Pastukh N; Nitzan O; Labay K; Aharon I; Brodsky D; Glyatman T; Peretz A
Am J Infect Control; 2015 Jul; 43(7):e19-22. PubMed ID: 25920705
[TBL] [Abstract][Full Text] [Related]
14. Catheter associated fungal urinary tract infection.
Suwitra K;
Acta Med Indones; 2004; 36(2):97-9. PubMed ID: 15673943
[No Abstract] [Full Text] [Related]
15. Oral fluconazole for Candida urinary tract infection.
Potasman I; Castin A; Moskovitz B; Srugo I; Nativ O
Urol Int; 1997; 59(4):252-6. PubMed ID: 9444745
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Tasneem U; Siddiqui MT; Faryal R; Shah AA
J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
[TBL] [Abstract][Full Text] [Related]
17. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
Kauffman CA; Vazquez JA; Sobel JD; Gallis HA; McKinsey DS; Karchmer AW; Sugar AM; Sharkey PK; Wise GJ; Mangi R; Mosher A; Lee JY; Dismukes WE
Clin Infect Dis; 2000 Jan; 30(1):14-8. PubMed ID: 10619726
[TBL] [Abstract][Full Text] [Related]
18. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
19. Clinician response to Candida organisms in the urine of patients attending hospital.
Chen SC; Tong ZS; Lee OC; Halliday C; Playford EG; Widmer F; Kong FR; Wu C; Sorrell TC
Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):201-8. PubMed ID: 18060438
[TBL] [Abstract][Full Text] [Related]
20. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
